Pustular eruption in a malaria patient treated with chloroquine. 1998

P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D012872 Skin Diseases, Vesiculobullous Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) Bullous Skin Diseases,Pustular Dermatosis, Subcorneal,Skin Diseases, Bullous,Skin Diseases, Vesicular,Sneddon-Wilkinson Disease,Subcorneal Pustular Dermatosis,Vesicular Skin Diseases,Vesiculobullous Skin Diseases,Bullous Dermatoses,Vesiculobullous Dermatoses,Bullous Skin Disease,Dermatoses, Bullous,Dermatoses, Subcorneal Pustular,Dermatoses, Vesiculobullous,Dermatosis, Subcorneal Pustular,Pustular Dermatoses, Subcorneal,Skin Disease, Bullous,Skin Disease, Vesicular,Skin Disease, Vesiculobullous,Sneddon Wilkinson Disease,Subcorneal Pustular Dermatoses,Vesicular Skin Disease,Vesiculobullous Skin Disease

Related Publications

P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
December 2017, JAMA dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
April 2018, JAMA dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
April 2018, JAMA dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
May 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
April 1990, Archives of dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
January 1967, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
June 1987, The Journal of dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
October 2002, Archives of dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
April 1994, The British journal of dermatology,
P Wilairatana, and S Looareesuwan, and M Riganti, and P Teja-Isavadharm, and D Keeratithakul, and S Eickmeyer, and D S Walsh
September 1998, The Journal of dermatology,
Copied contents to your clipboard!